Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow First Trust: 

Search by Ticker, Keyword or CUSIP       
 
 
First Trust Health Care AlphaDEX® Fund (FXH)
Investment Objective/Strategy - The First Trust Health Care AlphaDEX® Fund is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before fees and expenses, of an equity index called the StrataQuant® Health Care Index.
There can be no assurance that the Fund's investment objectives will be achieved.
  • The StrataQuant® Health Care Index is an "enhanced" index developed, maintained and sponsored by the NYSE Group, Inc. or its affiliates ("NYSE") which employs the AlphaDEX® stock selection methodology to select stocks from the Russell 1000® Index.
  • The NYSE constructs the StrataQuant® Health Care Index by ranking the stocks which are members of the Russell 1000® Index on growth factors including three, six and 12-month price appreciation, sales to price and one year sales growth, and, separately, on value factors including book value to price, cash flow to price and return on assets.
  • Stocks which Russell has classified solely as growth or value, receive their score using the above growth or value factors respectively.
  • Stocks which Russell allocates between both growth and value receive their best score between the growth and value factors.
  • The NYSE then ranks those stocks contained in the health care sector according to their score. The bottom 25% is eliminated and the top 75% is selected for the StrataQuant® Health Care Index.
  • The selected stocks are divided into quintiles based on their rankings and the top ranked quintiles receive a higher weight within the index. The stocks are equally-weighted within each quintile.
  • The index is reconstituted and rebalanced quarterly.
Fund Overview
TickerFXH
Fund TypeHealth Care
Investment AdvisorFirst Trust Advisors L.P.
Investor Servicing AgentBank of New York Mellon
CUSIP33734X143
ISINUS33734X1431
Intraday NAVFXHIV
Fiscal Year-End07/31
ExchangeNYSE Arca
Inception5/8/2007
Inception Price$20.00
Inception NAV$20.00
Rebalance FrequencyQuarterly
Gross Expense Ratio*0.66%
Net Expense Ratio*0.66%
* As of 12/1/2014
Expenses are capped contractually at 0.70% per year, at least until November 30, 2015.
Current Fund Data (as of 5/22/2015)
Closing NAV1$68.17
Closing Share Price2$68.23
Bid/Ask Midpoint$68.19
Bid/Ask Premium0.02%
Total Net Assets$3,667,754,502
Outstanding Shares53,800,002
Daily Volume201,733
Average 30-Day Daily Volume244,100
Closing Share Price 52-Week High/Low$68.72 / $51.26
Closing NAV 52-Week High/Low$68.69 / $51.27
Number of Holdings73
Fund Characteristics (as of 4/30/2015)3
Median Market Cap.$15,647
Maximum Market Cap.$281,839
Minimum Market Cap.$2,318
Price/Earnings26.90
Price/Book4.02
Price/Cash Flow15.78
Price/Sales1.21
Top Holdings (as of 5/26/2015)
Holding Percent
Incyte Corporation 2.75%
Aetna Inc. 2.51%
United Therapeutics Corporation 2.49%
McKesson Corporation 2.47%
Cigna Corporation 2.43%
BioMarin Pharmaceutical, Inc. 2.40%
Actavis Plc 2.37%
Catamaran Corp 2.37%
Centene Corporation 2.37%
Mallinckrodt Plc 2.35%

Holdings are subject to change.

NAV History (Since Inception)
Past performance is not indicative of future results.
Bid/Ask Midpoint vs. NAV (as of 3/31/2015)
Number of Days Bid/Ask Midpoint Above NAV
Quarter Ended 0-49
Basis Points
50-99
Basis Points
100-199
Basis Points
>=200
Basis Points
3/31/2015 56 0 0 0
12/31/2014 56 0 0 0
9/30/2014 58 0 0 0
6/30/2014 43 0 0 0
Number of Days Bid/Ask Midpoint Below NAV
Quarter Ended 0-49
Basis Points
50-99
Basis Points
100-199
Basis Points
>=200
Basis Points
3/31/2015 5 0 0 0
12/31/2014 8 0 0 0
9/30/2014 6 0 0 0
6/30/2014 20 0 0 0

The price used to calculate market return is determined by using the midpoint between the highest bid and the lowest offer on the stock exchange, on which shares of the Fund are listed for trading, as of the time that the Fund's NAV is calculated.

Top Industry Exposure (as of 5/26/2015)
Health Care Providers & Services 38.66%
Biotechnology 20.30%
Health Care Equipment & Supplies 16.84%
Pharmaceuticals 14.30%
Life Sciences Tools & Services 8.24%
Health Care Technology 1.66%
Month End Performance (as of 4/30/2015)
  3 Mos YTD 1 Year 3 Year 5 Year 10 Year Since
Fund
Inception4
Fund Performance *
NAV 5.90% 7.48% 30.49% 28.01% 22.46% N/A 15.97%
After Tax Held 5.90% 7.48% 30.49% 27.94% 22.40% N/A 15.93%
After Tax Sold 3.34% 4.23% 17.26% 22.42% 18.46% N/A 13.35%
Market Price 5.87% 7.43% 30.49% 28.02% 22.44% N/A 15.97%
Index Performance **
StrataQuant® Health Care Index 6.03% 7.68% 31.25% 28.90% 23.32% N/A 16.84%
Russell 1000® Health Care Index 4.20% 5.79% 26.77% 27.27% 21.30% N/A N/A
Russell 1000® Index 5.20% 2.31% 13.00% 16.95% 14.47% N/A 6.64%
S&P 500 Health Care Index 3.83% 5.10% 25.12% 26.38% 20.71% N/A 10.96%
Quarter End Performance (as of 3/31/2015)
  3 Mos YTD 1 Year 3 Year 5 Year 10 Year Since
Fund
Inception4
Fund Performance *
NAV 11.21% 11.21% 31.60% 29.82% 23.19% N/A 16.65%
After Tax Held 11.21% 11.21% 31.60% 29.76% 23.13% N/A 16.61%
After Tax Sold 6.35% 6.35% 17.89% 23.93% 19.10% N/A 13.95%
Market Price 11.16% 11.16% 31.57% 29.81% 23.17% N/A 16.65%
Index Performance **
StrataQuant® Health Care Index 11.35% 11.35% 32.36% 30.65% 24.07% N/A 17.53%
Russell 1000® Health Care Index 7.39% 7.39% 27.67% 27.93% 20.86% N/A N/A
Russell 1000® Index 1.59% 1.59% 12.73% 16.45% 14.73% N/A 6.62%
S&P 500 Health Care Index 6.53% 6.53% 26.19% 26.86% 20.09% N/A 11.27%
3-Year Statistics (as of 4/30/2015)
  Standard Deviation Alpha Beta Sharpe Ratio Correlation
FXH 12.46% -1.06 1.11 2.04 0.88
S&P 500 Health Care Index 9.93% --- 1.00 2.40 1.00
Standard Deviation is a measure of price variability (risk). Alpha is an indication of how much an investment outperforms or underperforms on a risk-adjusted basis relative to its benchmark.Beta is a measure of price variability relative to the market. Sharpe Ratio is a measure of excess reward per unit of volatility. Correlation is a measure of the similarity of performance.

*Performance data quoted represents past performance. Past performance is not a guarantee of future results and current performance may be higher or lower than performance quoted. Investment returns and principal value will fluctuate and shares when sold or redeemed, may be worth more or less than their original cost.

After Tax Held returns represent return after taxes on distributions. Assumes shares have not been sold. After Tax Sold returns represent the return after taxes on distributions and the sale of fund shares. Returns do not represent the returns you would receive if you traded shares at other times. Market Price returns are based on the midpoint of the bid/ask spread. Returns are average annualized total returns, except those for periods of less than one year, which are cumulative. The fund's performance reflects fee waivers and expense reimbursements, absent which performance would have been lower.

After-tax returns are calculated using the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes. Actual after-tax returns depend on the investor’s tax situation and may differ from those shown. The after-tax returns shown are not relevant to investors who hold their fund shares through tax-deferred arrangements such as 401(k) plans or individual retirement accounts.

**Performance information for the StrataQuant® Health Care Index is for illustrative purposes only and does not represent actual fund performance.
Indexes do not charge management fees or brokerage expenses, and no such fees or expenses were deducted from the performance shown. Indexes are unmanaged and an investor cannot invest directly in an index.
The gross expense ratio for this fund is 0.66%. Expenses are capped contractually at 0.70% per year, at least until November 30, 2015.

Russell 1000® Health Care Index - The Index is an unmanaged index which includes the stocks in the health care sector of the Russell 1000® Index.

Russell 1000® Index - The Index is an unmanaged index used to measure the large-cap U.S. equity universe.

S&P 500 Health Care Index - The Index is an unmanaged index which includes the stocks in the health care sector of the S&P 500 Index.

Footnotes
1 The NAV represents the fund's net assets (assets less liabilities) divided by the fund's shares outstanding.
2 Fund shares are purchased and sold on an exchange at their share price rather than net asset value (NAV), which may cause the shares to trade at a price greater than NAV (premium) or less than NAV (discount).
3 All market capitalization numbers are in USD$ Millions.
4 Inception Date is 5/8/2007

You should consider the fund's investment objectives, risks, and charges and expenses carefully before investing. You can download a prospectus or summary prospectus, or contact First Trust Portfolios L.P. at 1-800-621-1675 to request a prospectus or summary prospectus which contains this and other information about the fund. The prospectus or summary prospectus should be read carefully before investing.

ETF Characteristics

The fund lists and principally trades its shares on the NYSE Arca, Inc.

The fund's return may not match the return of the StrataQuant® Health Care Index.  Securities held by the fund will generally not be bought or sold in response to market fluctuations.

Investors buying or selling fund shares on the secondary market may incur customary brokerage commissions. Market prices may differ to some degree from the net asset value of the shares. Investors who sell fund shares may receive less than the share's net asset value. Shares may be sold throughout the day on the exchange through any brokerage account. However, unlike mutual funds, shares may only be redeemed directly from the fund by authorized participants, in very large creation/redemption units.

Risk Considerations

The fund's shares will change in value, and you could lose money by investing in the fund. One of the principal risks of investing in the fund is market risk. Market risk is the risk that a particular stock owned by the fund, fund shares or stocks in general may fall in value. There can be no assurance that the fund's investment objective will be achieved.

The fund may invest in small capitalization and mid capitalization companies. Such companies may experience greater price volatility than larger, more established companies.

Biotechnology and pharmaceutical companies are subject to extensive competition, generic drug sales or the loss of patent protection, product liability litigation and increased government regulation. Research and development costs of bringing new drugs to market are substantial, and there is no guarantee that the product will ever come to market. Health care facility operators may be affected by the demand for services, efforts by government or insurers to limit rates, restriction of government financial assistance and competition from other providers.

The fund is classified as "non-diversified" and may invest a relatively high percentage of its assets in a limited number of issuers. As a result, the fund may be more susceptible to a single adverse economic or regulatory occurrence affecting one or more of these issuers, experience increased volatility and be highly concentrated in certain issuers.

First Trust Advisors L.P. is the adviser to the fund. First Trust Advisors L.P. is an affiliate of First Trust Portfolios L.P., the fund's distributor.

The StrataQuant® Health Care Index is a trademark of the NYSE Group, Inc. or its affiliates ("NYSE") and has been licensed for use by First Trust Portfolios L.P. The fund is not sponsored, endorsed, sold or promoted by NYSE and NYSE makes no representation or warranty regarding the advisability of investing in the fund or as to the result to be obtained by any person from use of the index in connection with the trading of the fund.

Russell Investment Group is the source and owner of the trademarks, service marks and copyrights related to the Russell Indexes. Russell® is a trademark of the Russell Investment Group.

"AlphaDEX®" is a registered trademark of First Trust Portfolios L.P. First Trust Portfolios L.P. has obtained a patent for the AlphaDEX® stock selection methodology from the United States Patent and Trademark Office.

Not FDIC Insured • Not Bank Guaranteed • May Lose Value
 
First Trust Portfolios L.P.  Member SIPC and FINRA.
First Trust Advisors L.P.
Home |  Important Legal Information |  Privacy Policy |  Business Continuity Plan
Copyright © 2015 All rights reserved.